Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Raj Kumar Koiri
    Assistant Professor
    Department of Zoology
    Dr. Hari Singh Gour Central University
    India
    rkkoiri@dhsgsu.ac.in
    GJCT

    Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

    More Info.
    Peng Zhan
    Associate Professor
    Shandong University,
    China
    zhanpeng1982@163.com
    GJCT

    Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


    More Info.
    Yatendra Kumar Satija
    Yatendra Kumar Satija Molecular Oncology Lab
    National Institute of Immunology
    USA
    yksatija@gmail.com
    GJCT

    Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology

    More Info.
    Karim Essani
    Professor
    Department of Biological Sciences
    Western Michigan University
    USA
    karim.essani@wmich.edu
    GJCT
    Research Interest: Virus, Poxvirus, Tanapoxvirus, Virotherapy, Oncolytic viruses
    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    eselze82@gmail.com
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Manuel Aureliano
    Associate Professor
    University of Algarve
    Portugal
    maalves@ualg.pt
    GJCT

    Research Interest: Toxicology And Pharmaceutical Applications Of Decavanadate; Ii) Muscle Contraction And Regulation; Iii) Insulin Mimetic Compounds.


    More Info.
    Christopher Xin Jie Wong
    Centre for Heart Rhythm Disorders
    Royal Adelaide Hospital
    South Australia
    c.wong@adelaide.edu.au
    GJCT
    Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Qinong Ye
    Professor
    Department of Medical Molecular Biology/Oncology
    Beijing Institute of Biotechnology
    China
    yeqn66@yahoo.com
    GJCT

    Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response


    More Info.
    Grivas Nikolaos
    Associate Member of EAU
    University of Ioannina
    Greece
    ngrivas@cc.uoi.gr
    GJCT

    Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

    More Info.
    Ana Livia Silva Galbiatti
    Faculdade de Medicina de São José do Rio Preto
    Brazil
    analivia_sg@yahoo.com.br
    GJCT

    Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


    More Info.
    Jose Maria Pereira de Godoy
    Assistant Professor
    Regional Medical School
    egional Medical School, São José do Rio Preto
    Brazil
    godoyjmp@riopreto.com.br
    GJCT
    Research Interest: Breast CancerRehabilitationLymphedema  
    More Info.
    Xingding Zhang
    Assistant Professor
    Diagnosis and Nanomedicine Engineering Technology Center
    China
    ading5@hotmail.com
    GJCT

    Research Interest: Autophagy and Apoptosis


    More Info.
    Kailash Chadha
    Department of Molecular and Cellular Biology
    Roswell Park Cancer Institute
    USA
    Kailash.Chadha@RoswellPark.org
    GJCT

    Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.



    More Info.
    View more
    mendeley

    New modalities of surgery for renal tumors in children: A Mini-Review

    DOI Logo 10.17352/2581-5407.000049

    Published On: November 29, 2022 | Pages: 051 - 052

    Author(s): Jan Godzinski*
    Abstract View Full Article View
    mendeley

    Investigation of the effectiveness of ECOLAB ’Drape ArmourTM’ Radiation Protection in limiting eye-lens doses of healthcare personnel exposed to ionizing radiation during gastroenterology - interventional radiology procedures

    DOI Logo 10.17352/2581-5407.000048

    Published On: October 20, 2022 | Pages: 046 - 050

    Author(s): Fulvio IM Fucilli*, Giuseppe Di Giovanni, Alessandro Mastrorocco, Matteo Ninni, Piero Loprete, Isa De Crudis, Massimiliano Marano, Antonio Santomauro and Fabio Fucilli

    ORCID Logo  0000-0002-1132-0363

    Abstract View Full Article View
    mendeley

    The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

    DOI Logo 10.17352/2581-5407.000047

    Published On: October 11, 2022 | Pages: 040 - 045

    Author(s): Aslı Altun, Nurten Kara, Şengül Tural*, Alişan Yıldıran and Leman Tomak

    ORCID Logo  0000-0002-8946-8165

    Abstract View Full Article View
    mendeley

    A first comprehensive look at the order-disorder nature of RTK KIT native and carcinogenic targets

    DOI Logo 10.17352/2581-5407.000046

    Published On: October 07, 2022 | Pages: 036 - 039

    Author(s): Luba Tchertanov* and Julie Ledoux

    ORCID Logo  0000-0001-6600-5494

    Abstract View Full Article View
    mendeley

    Photodynamic therapy in a pleural cavity using monte carlo simulations with 2D/3D Graphical Visualization

    DOI Logo 10.17352/2581-5407.000045

    Published On: September 29, 2022 | Pages: 034 - 035

    Author(s): Beeson K, Parilov E, Mary Potasek*, Zhu T, Sun H and Sourvanos D
    Abstract View Full Article View    
    mendeley

    Clinical trials cannot provide sufficient accuracy for studying weak factors necessary for curing chronic diseases

    DOI Logo 10.17352/2581-5407.000044

    Published On: March 23, 2022 | Pages: 021 - 033

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    
    mendeley

    Surgery, Chemotherapy and Radiotherapy May Promote Cancer Growth Speeds and Shorten Patient Lives

    DOI Logo 10.17352/2581-5407.000043

    Published On: March 19, 2022 | Pages: 001 - 020

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    
    mendeley

    Patient’s experiences on receiving radiation therapy for head and neck cancer pre, pending and post treatment: A qualitative study at Bugando medical centre Mwanza, Tanzania

    DOI Logo 10.17352/2581-5407.000042

    Published On: August 23, 2021 | Pages: 046 - 049

    Author(s): Francis Kazoba* and Juston John
    Abstract View Full Article View    
    mendeley

    Assessment of the role of multimodality imaging for treatment volume definition of intracranial ependymal tumors: An original article

    DOI Logo 10.17352/2581-5407.000041

    Published On: July 06, 2021 | Pages: 043 - 045

    Author(s): Ferrat Dincoglan, Omer Sager*, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    
    mendeley

    Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

    DOI Logo 10.17352/2581-5407.000040

    Published On: May 19, 2021 | Pages: 035 - 042

    Author(s): Benjamin A Babalola*, Gboyega E Adebami and Samuel E Akinsuyi
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT

    Help ? Google Reviews 11